Aislinn Antrim

Aislinn Antrim connects clinical advances, regulation, and the evolving responsibilities of pharmacists, writing health coverage that shows how each new development reshapes patient care and pharmacy practice. As an associate editorial director at Pharmacy Times, she focuses on pharmacy-centered reporting on chronic disease therapeutics, specialty and oncology care, workforce pressures, and advocacy.

Clinical innovation and chronic disease management

Antrim’s health coverage consistently ties regulatory decisions and new evidence to real-world management of chronic disease. She reports on FDA actions such as the label update that allows semaglutide to be used as a first-line option for adults with type 2 diabetes, explaining what the change means for treatment algorithms and pharmacist counseling at the point of care. She breaks down complex policy shifts, including the FDA’s revised definition of “biologics” and “protein,” to show how classifying insulin as a biological product can open pathways to more affordable options through biosimilars and interchangeable products.

Her work tracks the pipeline of therapies and loss of exclusivity, as in coverage of drugs approaching patent expiration and the prospect of new generics entering the market. She highlights the clinical impact of immunologic therapies, reporting on perennial allergen immunotherapy and how sustained treatment can improve quality of life for patients with allergic rhinitis. In cardiometabolic care, her coverage of precision lipidology and advanced cardiac imaging at major lipid meetings reflects a focus on risk stratification and how emerging tools can be incorporated into pharmacist-led cardiovascular prevention programs.

Pharmacists’ role in specialty, oncology, and advocacy

Antrim’s reporting frequently centers pharmacists as integral members of specialty and oncology care teams. In her coverage of prostate cancer treatment, she moderates a detailed discussion with a clinical program manager that explores how pharmacists improve adherence, manage side effects, educate patients on administration and storage, and connect them with financial aid or support groups, all framed as part of the broader care team’s effort to keep patients on effective therapy. She uses similar expert conversations in specialty pharmacy to map the patient journey before treatment initiation, during access and benefit navigation, and through ongoing monitoring, underscoring pharmacists’ roles in coordinating labs, adjusting fills, and addressing adherence barriers during monthly assessments.

Her advocacy pieces show pharmacists operating beyond the dispensary to influence health policy. In coverage of professional advocacy, she highlights arguments that pharmacists should play active roles in legislative and regulatory debates, connecting policy engagement to patient access and safety. She also addresses public health and stigma, reporting on how stigma around HIV prevents health systems from fully applying lessons from the HIV epidemic to the COVID-19 pandemic, drawing a line between social attitudes, disease control, and the design of patient-centered care.

Workforce pressures and the future of pharmacy practice

Antrim’s health beat extends into the human and operational side of pharmacy, documenting the conditions under which pharmacists work. Her reporting on pharmacist burnout captures high levels of stress, understaffing, and a trend toward exploring alternative career paths, linking survey findings to consequences for patient care and store operations. She connects workforce realities with broader shifts in the drug landscape, such as patent expirations and generic entry, to show how economic pressures and changing inventories intersect with staffing and service models.

Her features on the next generation of pharmacists add texture to this future-facing view. In coverage of pharmacy students using Instagram, she profiles how students share their unique experiences and perspectives, using social media to build professional identity and community within the pharmacy space. Earlier experience reporting on education gives her an additional lens on systems, institutions, and training pathways, which informs her attention to how health and education structures shape the profession over time.

Interview-driven coverage and editorial leadership

A significant portion of Antrim’s work is interview-driven, giving readers direct access to clinical leaders, health-system pharmacists, and policy experts. In video and transcript formats, she introduces segments and guides conversations with focused questions that elicit practical guidance on access, adherence, side-effect management, and collaborative practice between pharmacists and prescribers. These pieces translate specialist insights into actionable information for frontline pharmacy professionals while maintaining a clear structure around patient outcomes and care coordination.

Alongside her reporting, Antrim holds a central editorial role shaping the masthead’s clinical and practice coverage. Submission guidelines for Pharmacy Times direct authors for web and print, as well as related practice and careers publications, to route manuscripts through her, indicating that she oversees article intake and helps curate content across student, mental health, practice, and research formats. This combination of hands-on reporting, expert moderation, and editorial decision-making gives her work a through-line: pharmacy-focused health journalism that stays close to the dispenser, attentive to policy and science, and grounded in how pharmacists deliver care to patients.